The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials
Crossref DOI link: https://doi.org/10.1007/s00125-021-05529-w
Published Online: 2021-09-18
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Donna Shu-Han
Lee, Jen-Kuang
Hung, Chi-Sheng
Chen, Wen-Jone
Text and Data Mining valid from 2021-09-18
Version of Record valid from 2021-09-18
Article History
Received: 13 January 2021
Accepted: 23 April 2021
First Online: 18 September 2021
Free to read: This content has been made available to all.